3β-Ursodeoxycholic acid
CAT:
804-HY-113478-01
Size:
5 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

3β-Ursodeoxycholic acid
- Product Name Alternative: DGAT-1 Inhibitor 4a
- CAS Number: 78919-26-3
- UNSPSC Description: 3β-Ursodeoxycholic acid (Isoursodeoxycholic acid) is a bile acid. 3β-Ursodeoxycholic acid shows good tolerance and well intestinal absorption by oral adminstation. 3β-Ursodeoxycholic acid can be isomerized by intestinal and hepatic enzymes to yield UDCA[1].
- Target Antigen: Others
- Type: Reference compound
- Related Pathways: Others
- Field of Research: Metabolic Disease
- Assay Protocol: https://www.medchemexpress.com/3β-ursodeoxycholic-acid.html
- Purity: 99.88
- Solubility: DMSO : 100 mg/mL (ultrasonic)
- Smiles: C[C@@]12[C@](CC[C@]2([H])[C@H](C)CCC(O)=O)([H])[C@@]3([H])[C@@](CC1)([H])[C@@]4([C@](C[C@H](CC4)O)([H])C[C@@H]3O)C
- Molecular Weight: 392.57
- References & Citations: [1]Professor Dr. W, et al. Study of human isoursodeoxycholic acid metabolism.Journal of Hepatology.Volume 26, Issue 4, April 1997, Pages 863-870|[2]Purucker E, et al., Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats. Biochim Biophys Acta. 2001 Apr 3;1526(1):44-52.
- Shipping Conditions: Room Temperature
- Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
- Clinical Information: No Development Reported